Navigation Links
Kensey Nash Investor Conference Schedule
Date:8/30/2011

EXTON, Pa., Aug. 30, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) is scheduled to present at the following investor conferences in September.

Kensey Nash will be participating at the Barrington Research Growth Conference 2011 in Chicago on Wednesday, September 7th, 2011.  The presentation materials will be available on the company's website (www.kenseynash.com) at 8:00 a.m. ET on Wednesday, September 7th, 2011.

Michael Celano, Kensey Nash's Chief Financial Officer, will deliver the Company's presentation, at the CL King's 9th Annual Best Ideas Conference at the Omni Berkshire Place Hotel in New York on Tuesday, September 13th, 2011 at 3:45 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.videonewswire.com/event.asp?id=81468.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 3:45 p.m. (ET) on Tuesday, September 13th, 2011.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, at the UBS Global Life Sciences Conference at the Grand Hyatt Hotel in New York on Wednesday, September 21st, 2011 beginning at approximately at 9:00 a.m. (ET).  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 9:00 a.m. (ET) on Wednesday, September 21st, 2011.

Joseph W. Kaufmann will deliver the Company's presentation at the Jefferies 2011 Global Healthcare Conference in London on Tuesday, September 27th, 2011 beginning approximately at 10:00 p.m. (ET).  To hear the live webcast of the Kensey Nash presentation, go to http://www.wsw.com/webcast/jeff62/knsy/.  The webcast will be archived for ninety days following the live presentation.  The presentation materials will also be available on the company's website (www.kenseynash.com) beginning at 10:00 p.m. (ET) on Tuesday, September 27th, 2011.

About Kensey Nash Corporation. Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technology.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products, which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit www.kenseynash.com.


'/>"/>
SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kensey Nash Reports Fourth Quarter and Full Fiscal Year 2011 Financial Results
2. Kensey Nash Corporation Announces Its Fourth Quarter and Fiscal Year End 2011 Earnings Release Date and Teleconference
3. Kensey Nash Announces New Unsecured Revolving Credit Facility
4. Kensey Nash to Present at the Jefferies 2011 Global Healthcare Conference
5. Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
6. Kensey Nash to Present at the Canaccord Genuity Musculoskeletal Conference
7. Kensey Nash Corporation Announces Its Second Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
8. Kensey Nash Announces a Manufacturing Agreement with and Minority Investment in Orteq Sports Medicine
9. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
10. Kensey Nash to Present at Two Investor Conferences in November
11. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):